Alpha Tau Medical Ltd

NASDAQ DRTS

Data sourced from

and

Download Data

Alpha Tau Medical Ltd Revenue Per Share 1 year YoY Change (%) for the Trailing 12 Months (TTM) ending September 19, 2024

Alpha Tau Medical Ltd Revenue Per Share 1 year YoY Change (%) is NA for the Trailing 12 Months (TTM) ending September 19, 2024. Revenue per share measures the amount of revenue generated by a company per outstanding share. It is calculated by dividing the revenue by the number of outstanding shares (weighted average). This ratio provides insights into the company's revenue generation on a per-share basis. A higher revenue per share indicates stronger revenue performance and potentially higher value per share for investors. The measure "Change (%)" refers to the percentage change in the value of a financial metric between two time points. This measure provides a relative perspective on the magnitude of change.

Alpha Tau Medical Ltd Revenue Per Share for the Trailing 12 Months (TTM) ending March 31, 2023 was USD 0.00, a 0.00% change year over year.
Alpha Tau Medical Ltd Revenue Per Share for the Trailing 12 Months (TTM) ending March 31, 2022 was USD 0.00, a 0.00% change year over year.
Alpha Tau Medical Ltd Revenue Per Share for the Trailing 12 Months (TTM) ending March 31, 2021 was USD 0.00.

NASDAQ: DRTS

Alpha Tau Medical Ltd

CEO	Mr. Uzi Sofer
IPO Date	March 8, 2021
Location	Israel
Headquarters	5 Kiryat Hamada Street, Jerusalem, Israel, 9777605
Employees	121
Sector	Healthcare
Industry	Biotechnology

Description

Alpha Tau Medical Ltd., a clinical-stage oncology therapeutics company, engages in research, development, and commercialization of diffusing alpha-emitters radiation therapy (Alpha DaRT) for the treatment of solid cancer In Israel and the United States. The company's Alpha-DaRT technology is in clinical trials for various forms comprising skin, oral, pancreatic, prostate, lung, liver, and breast cancers; preclinical or pending clinical studies for brain and other cancers; and preclinical studies for hepatic cell carcinoma, glioblastoma multiforme, lung cancer, and others. Alpha Tau Medical Ltd. was incorporated in 2015 and is headquartered in Jerusalem, Israel.

Key trends